Evidence map›Paper›PMID 40909961›Full record

ArticleFrontiers in oncology2025

Scrotal hemangioma: a case report and systematic literature review.

Zhe Chang, Jiangwei Man, Jirong Wang, Huiming Gui, Jiping Niu, Li Yang

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhe ChangDepartment of Urology, The Second Hospital of Lanzhou University, Lanzhou, China.
Jiangwei ManDepartment of Urology, The Second Hospital of Lanzhou University, Lanzhou, China.
Jirong WangDepartment of Urology, The Second Hospital of Lanzhou University, Lanzhou, China.
Huiming GuiDepartment of Urology, The Second Hospital of Lanzhou University, Lanzhou, China.
Jiping NiuDepartment of Urology, The Second Hospital of Lanzhou University, Lanzhou, China.
Li YangDepartment of Urology, The Second Hospital of Lanzhou University, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to provide a case of scrotal hemangioma and examine its characteristics. Methods: We presented a case report involving a sixteen-year-old male, detailing symptoms, physical examination, imaging studies, diagnosis, and treatment. We conducted a thorough literature analysis of case reports and examined their clinical characteristics, pathological categorization, recurrence, and complications. Results: Our study comprised 21 patients with scrotal hemangioma. The average age was 27.14 years, with a range from 21 days to 84 years. 57.1% of the hemangiomas affected the organs. 61.9% of patients were situated on the right side of the scrotum. Ninety percent of patients experienced no pain. Merely 33.3% of patients exhibited additional symptoms, which encompassed azoospermia, hemorrhage, calcification, hydrocele, thrombosis, and ulceration. The predominant pathological classification was cavernous scrotal hemangioma, representing 38.1% of the cases. All patients received surgical resection, and the majority experienced neither relapse nor postoperative complications. Conclusions: Scrotal hemangioma, an uncommon benign neoplasm in adolescents, frequently remains asymptomatic but may disrupt fertility and, in rare instances, lead to severe problems. Timely identification, diagnosis, and surgical intervention are essential for good patient outcomes.

Indexed as

cavernous hemangiomadiagnosis and prognosisscrotum hemangiomascrotum tumorsurgical treatment

Identifiers

PMID40909961
PMCPMC12404914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.